2026-04-29T02:55:47Zhttps://riubu.ubu.es/oai/requestoai:riubu.ubu.es:10259/88512024-03-20T01:05:14Zcom_10259_4219com_10259_5086com_10259_2604col_10259_4220
Towns, Clodagh
Richer, Madeleine
Jasaityte, Simona
Stafford, Eleanor J.
Joubert, Julie
Antar, Tarek
Martínez Carrasco, Alejandro
Makarious, Mary B.
Casey, Bradford
Vitale, Dan
Levine, Kristin
Leonard, Hampton
Pantazis, Caroline B.
Screven, Laurel A.
Hernández, Dena G.
Wegel, Claire E.
Solle, Justin
Nalls, Mike A.
Blauwendraat, Cornelis
Singleton, Andrew B.
Tan, Manuela M. X.
Iwaki, Hirotaka
Morris, Huw R.
Cubo Delgado, Esther
Global Parkinson's Genetics Program
2024-03-19T12:40:06Z
2024-03-19T12:40:06Z
2023-09
http://hdl.handle.net/10259/8851
10.1038/s41531-023-00533-w
2373-8057
The Global Parkinson’s Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia.
application/pdf
eng
Springer Nature
npj Parkinson's Disease. 2023, V. 9, n. 1
https://doi.org/10.1038/s41531-023-00533-w
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
Sistema nervioso-Enfermedades
Medicina
Neurología
Nervous system-Diseases
Medicine
Neurology
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
npj Parkinson's Disease
9
1